• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病对 COVID-19 相关住院死亡率的影响:来自意大利北部的回顾性研究。

Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy.

机构信息

Department of Medicine and Surgery, Università degli Studi di Milano Bicocca, Milan, Italy.

Department of Medicine and Rehabilitation, Policlinico di Monza, Via Modigliani 10, 20900, Monza, MB, Italy.

出版信息

J Endocrinol Invest. 2021 Apr;44(4):843-850. doi: 10.1007/s40618-020-01382-7. Epub 2020 Aug 10.

DOI:10.1007/s40618-020-01382-7
PMID:32776197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7415410/
Abstract

PURPOSE

The purpose of this study was to evaluate the impact of pre-existing diabetes on in-hospital mortality in patients admitted for Coronavirus Disease 2019 (COVID-19).

METHODS

This is a single center, retrospective study conducted at Policlinico di Monza hospital, located in the Lombardy region, Northern Italy. We reviewed medical records of 373 consecutive adult patients who were hospitalized with COVID-19 between February 22 and May 15, 2020. Data were collected on diabetes status, comorbid conditions and laboratory findings. Multivariable logistic regression was performed to evaluate the effect of diabetes on in-hospital mortality after adjustment for potential confounding variables.

RESULTS

Mean age of the patients was 72 ± 14 years (range 17-98), 244 (65.4%) were male and 69 (18.5%) had diabetes. The most common comorbid conditions were hypertension (237 [64.8%]), cardiovascular disease (140 [37.7%]) and malignant neoplasms (50 [13.6%]). In-hospital death occurred in 142 (38.0%) patients. In the multivariable model older age (Relative Risk [RR] 1.06 [1.04-1. 09] per year), diabetes (RR 1.56 [1.05-2.02]), chronic obstructive pulmonary disease (RR 1.82 [1.13-2.35]), higher values of lactic dehydrogenase and C-reactive protein were independently associated with in-hospital mortality.

CONCLUSION

In this retrospective single-center study, diabetes was independently associated with a higher in-hospital mortality. More intensive surveillance of patients with this condition is to be warranted.

摘要

目的

本研究旨在评估患有 2019 年冠状病毒病(COVID-19)的患者中预先存在的糖尿病对住院死亡率的影响。

方法

这是一项在意大利北部伦巴第大区蒙扎综合医院进行的单中心回顾性研究。我们回顾了 2020 年 2 月 22 日至 5 月 15 日期间因 COVID-19 住院的 373 例连续成年患者的病历。收集了糖尿病状态、合并症和实验室检查结果的数据。多变量逻辑回归用于评估在调整潜在混杂因素后,糖尿病对住院死亡率的影响。

结果

患者的平均年龄为 72±14 岁(范围 17-98),244 例(65.4%)为男性,69 例(18.5%)患有糖尿病。最常见的合并症是高血压(237 例[64.8%])、心血管疾病(140 例[37.7%])和恶性肿瘤(50 例[13.6%])。住院期间有 142 例(38.0%)患者死亡。在多变量模型中,年龄较大(每增加 1 岁,相对风险[RR]为 1.06[1.04-1.09])、糖尿病(RR 1.56[1.05-2.02])、慢性阻塞性肺疾病(RR 1.82[1.13-2.35])、乳酸脱氢酶和 C 反应蛋白值较高与住院死亡率独立相关。

结论

在这项回顾性单中心研究中,糖尿病与较高的住院死亡率独立相关。需要对患有这种疾病的患者进行更密切的监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8a/7946676/540c632f68df/40618_2020_1382_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8a/7946676/540c632f68df/40618_2020_1382_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8a/7946676/540c632f68df/40618_2020_1382_Fig1_HTML.jpg

相似文献

1
Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy.糖尿病对 COVID-19 相关住院死亡率的影响:来自意大利北部的回顾性研究。
J Endocrinol Invest. 2021 Apr;44(4):843-850. doi: 10.1007/s40618-020-01382-7. Epub 2020 Aug 10.
2
Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy.维生素 D 与 COVID-19 严重程度和相关死亡率:意大利的一项前瞻性研究。
BMC Infect Dis. 2021 Jun 14;21(1):566. doi: 10.1186/s12879-021-06281-7.
3
Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.鉴定 COVID-19 肺炎院内死亡的风险因素——来自早期爆发的教训。
BMC Infect Dis. 2021 Jan 25;21(1):113. doi: 10.1186/s12879-021-05814-4.
4
Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.心血管危险因素和心血管疾病对大邱市 COVID-19 住院患者结局的影响。
J Korean Med Sci. 2021 Jan 11;36(2):e15. doi: 10.3346/jkms.2021.36.e15.
5
Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.墨西哥门诊和住院患者严重急性呼吸综合征冠状病毒 2 感染后生存的决定因素。
Public Health. 2020 Dec;189:66-72. doi: 10.1016/j.puhe.2020.09.014. Epub 2020 Sep 30.
6
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.中国武汉 COVID-19 合并糖尿病患者的临床特征和死亡危险因素:一项两中心回顾性研究。
Diabetes Care. 2020 Jul;43(7):1382-1391. doi: 10.2337/dc20-0598. Epub 2020 May 14.
7
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy.意大利米兰新冠疫情临床结局的早期预测指标。
Clin Immunol. 2020 Aug;217:108509. doi: 10.1016/j.clim.2020.108509. Epub 2020 Jun 12.
8
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study.肌钙蛋白水平与意大利住院 2019 冠状病毒病患者死亡率的相关性:一项多中心研究结果。
JAMA Cardiol. 2020 Nov 1;5(11):1274-1280. doi: 10.1001/jamacardio.2020.3538.
9
[Chronic diseases and risk of symptomatic COVID-19: results of a case-population study on a sample of patients in the Local Health Unit 'Toscana Centro' (Tuscany Region, Central Italy)].[慢性病与有症状的2019冠状病毒病风险:对托斯卡纳中心地方卫生单位(意大利中部托斯卡纳大区)患者样本的病例-人群研究结果]
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):308-314. doi: 10.19191/EP20.5-6.S2.131.
10
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19.在 SARS-CoV-2 大流行期间,大量患者入院对 COVID-19 的院内死亡率有独立的有害影响。
PLoS One. 2021 Jan 28;16(1):e0246170. doi: 10.1371/journal.pone.0246170. eCollection 2021.

引用本文的文献

1
Association among diabetes, cardiovascular disease and mortality in patients hospitalised for COVID-19: an analysis of the American Heart Association COVID-19 CVD Registry.2019冠状病毒病住院患者中糖尿病、心血管疾病与死亡率之间的关联:美国心脏协会2019冠状病毒病心血管疾病注册研究分析
BMJ Open. 2024 Dec 4;14(12):e084087. doi: 10.1136/bmjopen-2024-084087.
2
A deep transfer learning approach for COVID-19 detection and exploring a sense of belonging with Diabetes.一种用于 COVID-19 检测的深度迁移学习方法及对糖尿病归属感的探索。
Front Public Health. 2023 Nov 6;11:1308404. doi: 10.3389/fpubh.2023.1308404. eCollection 2023.
3

本文引用的文献

1
The role of the microbiome in diabetes mellitus.微生物组在糖尿病中的作用。
Diabetes Res Clin Pract. 2021 Feb;172:108645. doi: 10.1016/j.diabres.2020.108645. Epub 2020 Dec 24.
2
Association of Serum Bile Acids Profile and Pathway Dysregulation With the Risk of Developing Diabetes Among Normoglycemic Chinese Adults: Findings From the 4C Study.血清胆汁酸谱和途径失调与中国血糖正常成年人发生糖尿病风险的关联:来自 4C 研究的结果。
Diabetes Care. 2021 Feb;44(2):499-510. doi: 10.2337/dc20-0884. Epub 2020 Dec 18.
3
NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment.
Association of government effectiveness, logistics performance, IT systems and income with COVID-19 mortality.
政府效能、物流绩效、信息技术系统及收入与新冠肺炎死亡率的关联
Heliyon. 2023 Apr;9(4):e15214. doi: 10.1016/j.heliyon.2023.e15214. Epub 2023 Apr 5.
4
Predictors of mortality and ICU requirement in hospitalized COVID-19 patients with diabetes: A multicentre study.住院 COVID-19 合并糖尿病患者的死亡率和 ICU 需求的预测因素:一项多中心研究。
Nurs Open. 2023 May;10(5):3178-3190. doi: 10.1002/nop2.1567. Epub 2022 Dec 27.
5
Interpretable Machine Learning for Inpatient COVID-19 Mortality Risk Assessments: Diabetes Mellitus Exclusive Interplay.用于住院 COVID-19 死亡率评估的可解释机器学习:糖尿病的独特作用。
Sensors (Basel). 2022 Nov 12;22(22):8757. doi: 10.3390/s22228757.
6
Clinical and laboratory profile and outcomes of hospitalized COVID-19 patients with type 2 diabetes mellitus in Ghana - A single-center study.加纳住院 COVID-19 合并 2 型糖尿病患者的临床和实验室特征及转归:一项单中心研究。
Endocrinol Diabetes Metab. 2023 Jan;6(1):e391. doi: 10.1002/edm2.391. Epub 2022 Nov 25.
7
Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe.因严重急性呼吸综合征冠状病毒 2 型导致的死亡率、重症监护病房和医院收治的预后因素:欧洲队列研究的系统评价和荟萃分析。
Eur Respir Rev. 2022 Nov 2;31(166). doi: 10.1183/16000617.0098-2022. Print 2022 Dec 31.
8
COVID-19 and arrhythmia: The factors associated and the role of myocardial electrical impulse propagation. An observational study based on cardiac telemetric monitoring.新型冠状病毒肺炎与心律失常:相关因素及心肌电冲动传导的作用。一项基于心脏遥测监测的观察性研究。
Front Cardiovasc Med. 2022 Sep 7;9:912474. doi: 10.3389/fcvm.2022.912474. eCollection 2022.
9
Diabetes and SARS-CoV-2-Is There a Mutual Connection?糖尿病与严重急性呼吸综合征冠状病毒2型——它们之间存在相互联系吗?
Front Cell Dev Biol. 2022 Jun 13;10:913305. doi: 10.3389/fcell.2022.913305. eCollection 2022.
10
J-shaped associations and joint effects of fasting glucose with inflammation and cytokines on COVID-19 mortality.空腹血糖与炎症和细胞因子对 COVID-19 死亡率的 J 型关联及联合作用。
Int J Infect Dis. 2022 Sep;122:285-294. doi: 10.1016/j.ijid.2022.05.060. Epub 2022 Jun 1.
非酒精性脂肪性肝病,以及心血管和心脏疾病:影响风险、预测和治疗的因素。
Diabetes Metab. 2021 Mar;47(2):101215. doi: 10.1016/j.diabet.2020.101215. Epub 2020 Dec 6.
4
Application of new international classification of adult-onset diabetes in Chinese inpatients with diabetes mellitus.成人发病型糖尿病新国际分类在中国糖尿病住院患者中的应用。
Diabetes Metab Res Rev. 2021 Oct;37(7):e3427. doi: 10.1002/dmrr.3427. Epub 2020 Dec 12.
5
Early Spread of SARS-CoV-2 in the Icelandic Population. Reply.严重急性呼吸综合征冠状病毒2在冰岛人群中的早期传播。回复。
N Engl J Med. 2020 Nov 26;383(22):2184-2185. doi: 10.1056/NEJMc2027653. Epub 2020 Nov 4.
6
RAAS Inhibitors and Risk of Covid-19. Reply.肾素-血管紧张素-醛固酮系统(RAAS)抑制剂与2019冠状病毒病(Covid-19)风险。回复。
N Engl J Med. 2020 Nov 12;383(20):1993. doi: 10.1056/NEJMc2030446. Epub 2020 Oct 27.
7
A Response To: Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions.对《钠-葡萄糖协同转运蛋白2抑制剂与主要新冠病毒疾病结局:有前景的机制、相互矛盾的数据及引人关注的临床决策》的回应
Diabetes Ther. 2020 Dec;11(12):3007-3009. doi: 10.1007/s13300-020-00943-6. Epub 2020 Oct 14.
8
Exposure to dipeptidyl-peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta-analysis.二肽基肽酶 4 抑制剂暴露与 2 型糖尿病患者肺炎风险:回顾性队列研究和荟萃分析。
Diabetes Obes Metab. 2020 Oct;22(10):1925-1934. doi: 10.1111/dom.14142. Epub 2020 Aug 25.
9
Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension.年龄和多种合并症预测 COVID-19 患者的死亡:意大利高血压学会 SARS-RAS 研究的结果。
Hypertension. 2020 Aug;76(2):366-372. doi: 10.1161/HYPERTENSIONAHA.120.15324. Epub 2020 Jun 22.
10
Clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years.≥80 岁 COVID-19 患者的临床特征和预后因素。
Geriatr Gerontol Int. 2020 Jul;20(7):704-708. doi: 10.1111/ggi.13960. Epub 2020 Jun 9.